Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion type Assertion NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_head.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion description "[Silencing FLIP expression significantly increased human sarcoma cells to both FasL-induced and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, and ectopic expression of IRF8 also significantly increased the sensitivity of these human sarcoma cells to FasL- and TRAIL-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_provenance.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion evidence source_evidence_literature NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_provenance.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion SIO_000772 19155307 NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_provenance.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion wasDerivedFrom befree-2016 NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_provenance.
- NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_assertion wasGeneratedBy ECO_0000203 NP715485.RA2e2USV4sZVCfYxLg_5a0i4nN1WEi9XdTiqNff_UIKwk130_provenance.